SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-06-059153
Filing Date
2006-03-20
Accepted
2006-03-20 17:15:22
Documents
3
Period of Report
2006-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO FORM 8-K d8ka.htm 8-K/A 15800
2 PRESS RELEASE dex991.htm EX-99.1 196515
3 GRAPHIC g23796image1.jpg GRAPHIC 18345
  Complete submission text file 0001193125-06-059153.txt   239346
Mailing Address 34801 CAMPUS DR FREMONT CA 94555
Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-19756 | Film No.: 06699348
SIC: 2836 Biological Products, (No Diagnostic Substances)